Cardiomyopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Lina Yaqoub (talk | contribs) |
Lina Yaqoub (talk | contribs) |
||
| Line 15: | Line 15: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
* | *Incidence and prevalence differ based on cause. | ||
*The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. | *The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized. | ||
Revision as of 00:25, 28 November 2018
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics |
|
Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
References
- Incidence and prevalence differ based on cause.
- The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.
- The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 1:500 of the adult population.
- RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.